Medibank Private Ltd’s Shares Make a Positive Start at $2.92 Opening Price
January 17, 2023
Trending News ☀️
Medibank Private Stock Fair Value – It is a publicly listed company, trading on the Australian Stock Exchange (ASX). On Monday, January 09, the opening price of Medibank Private ($ASX:MPL) Ltd’s shares was $2.92, making a positive start in the market. This can be attributed to the company’s strong financial performance and its ability to keep its customers happy. The company has also been investing heavily in its digital capabilities and technology, which is helping to drive customer satisfaction and loyalty.
Medibank Private Ltd’s new ‘My Medibank’ mobile app has been a hit with customers and offers a range of features such as allowing customers to view and manage their cover, submit claims, access discounts and rewards, and seek medical advice. The positive start of Medibank Private Ltd’s share price on Monday, January 09 is indicative of the company’s strong performance and its commitment to providing quality health insurance products and services. With continued investment in technology, innovation and customer service, Medibank Private Ltd is well-positioned to capitalise on future growth opportunities.
Price History
This opening price was higher than the previous closing price of AU$2.9, signifying a positive start for the company. Despite this positive start, the stock closed at AU$2.9, which was a 1% decrease from the previous day’s closing price. Analysts had predicted a strong opening for MEDIBANK PRIVATE Ltd’s shares, given their impressive performance in the past year. This interest was evident in the positive opening of the company’s stock on Tuesday. Investors were also buoyed by the fact that the company had recently announced solid financial results for the first half of the year.
MEDIBANK PRIVATE Ltd’s revenue had grown significantly during this period, and the company was confident that it could maintain its strong performance going forward. This gave investors confidence that their investments in MEDIBANK PRIVATE Ltd were well placed. This was largely attributed to the company’s impressive financial performance in recent months and its outlook for the future. With investors continuing to show confidence in the company, MEDIBANK PRIVATE Ltd’s future looks bright and its stock could be set to rise further in the near future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Medibank Private. More…
| Total Revenues | Net Income | Net Margin |
| 7.09k | 393.9 | 5.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Medibank Private. More…
| Operations | Investing | Financing |
| 948.5 | -623.6 | -399.9 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Medibank Private. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 4.55k | 2.61k | 0.71 |
Key Ratios Snapshot
Some of the financial key ratios for Medibank Private are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 1.7% | – | 7.9% |
| FCF Margin | ROE | ROA |
| 12.9% | 18.1% | 7.7% |
VI Analysis – Medibank Private Stock Fair Value
Company fundamentals are a key indicator of a company’s long term potential, and the VI app makes it easy for investors to assess this. VI Line has calculated that the fair value of MEDIBANK PRIVATE shares is around AU$3.3. Currently, the stock is trading at AU$2.9, meaning it is undervalued by 11%. This indicates that there is potential to make a good return due to the discrepancy between current and fair value. When considering investing in stocks, investors should carefully consider the company’s fundamentals. This includes analyzing its financial statements, looking at its competitive environment, and assessing any risks associated with the company. The VI app provides a quick and easy way to access this information and make an informed decision when it comes to investing. For MEDIBANK PRIVATE, the app allows investors to quickly see that the stock is undervalued and could offer a good return if purchased. However, it is important to remember that investing involves risk and no guarantee of a return. It is important to do thorough research and understand the associated risks before making any investment decisions. More…
VI Peers
In the insurance industry in Australia, there is high competition between Medibank Private Ltd and its competitors: NIB Holdings Ltd, Star Health and Allied Insurance Co Ltd, Discovery Ltd. All of these companies offer a variety of health insurance plans with different features and benefits.
However, Medibank Private Ltd is the largest provider of health insurance in Australia. It has a wide range of products and services, as well as a strong brand presence. The company also has a large customer base and a strong distribution network.
– NIB Holdings Ltd ($ASX:NHF)
NIB Holdings Ltd is an Australian company that provides health insurance products and services. The company has a market capitalization of $3.26 billion as of 2022 and a return on equity of 22.39%. NIB Holdings Ltd offers a range of health insurance products including hospital, extras, and ancillary cover. The company operates in Australia, New Zealand, and the United Kingdom.
– Star Health and Allied Insurance Co Ltd ($BSE:543412)
Star Health and Allied Insurance Co Ltd is a health insurance company with a market cap of 419.29B as of 2022. The company has a Return on Equity of -21.69%. The company offers health insurance products and services to individuals and businesses. The company operates in India and the United Arab Emirates.
– Discovery Ltd ($OTCPK:DCYHY)
The company’s market cap is 4.09B as of 2022. The company’s ROE is 10.75%. The company is involved in the discovery and development of new drugs and therapies.
Summary
Medibank Private Ltd, Australia’s largest private health insurer, has seen its shares make a positive start on the ASX, opening at $2.92 per share. Analysts are optimistic about the company’s prospects, with many expecting a rise in share price over the coming months. Factors supporting this include Medibank’s strong financial position and its ability to capitalize on an aging population and increasing demand for private health services. Its solid balance sheet and cash flow from operations also provide a strong foundation for growth.
Furthermore, Medibank’s broad portfolio of products and services across different markets provides significant diversification and resilience to market downturns. These factors, combined with its attractive dividend yield, have made Medibank Private a highly attractive investment for many investors.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
